Mobile

Study in adults aged between 18 and 45 years to evaluate the reactogenicity and the immunogenicity of an experimental administration of GlaxoSmithKline Biologicals' Fluarix vaccine (known as a-Rix in ...

Update Il y a 5 ans
Reference: GSK104440-002

Study in adults aged between 18 and 45 years to evaluate the reactogenicity and the immunogenicity of an experimental administration of GlaxoSmithKline Biologicals' Fluarix vaccine (known as a-Rix in Belgium). Standard intramuscular and subcutaneous vaccine administration will be used as references

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

Links